Skip to main content
OpenTrials
Completed

NCT Number: NCT04555759

Validity and Reliability of the 2-minute Walk Test in Individuals With a Spinal Cord Injury

There exist a variety of outcome measures to asses gait function in individuals with a spinal cord injury (SCI). The most established measures are the 10-meter walk test (10MWT) and the 6-minute walk test (6mWT). They are used to assess treatment efficacy and recovery of gait function in individuals with SCI. However, the 10MWT is appropriate for poor walkers but not sensitive in good walkers and the 6mWT can be time-consuming and is very demanding for severely impaired patients. Therefore the 2-minute walk test (2mWT) has gained more attention in the SCI field. The 2mWT has been established in numerous neurological diseases and has shown to correlate with the 6mWT in patients with neuromuscular disease, multiple sclerosis and stroke. Though the 2mWT has not yet been validated in individuals with SCI.

A limitation that affects all timed walking tests is that they suffer from limited information about gait quality (i.e. how walking function is achieved). Being able to receive information on the gait quality of a patient can help to understand the underlying mechanisms of walking improvements after an intervention (e.g. compensation vs recovery). The research in the field of inertia measuring units (IMU) develops and advances very rapidly at the moment resulting in the possibility to perform a gait analysis with a simple IMU setup. However, the reliability of such measurement setups has not yet been shown in individuals with SCI.

The primary aim of this study is to test the validity and reliability of the 2mWT in the SCI population.

Additionally, it will be investigated if a simple sensor setup can give additional reliable information about the gait pattern of individuals with SCI.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Schweizer Paraplegiker-Zentrum, Nottwil, Switzerland

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants fulfilling all of the following inclusion criteria are eligible for the study:
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • At least 18 years old
  • Spinal cord injury
  • Able to walk with a speed of at least 0.17m/s with or without walking devices and or bracing

Exclusion criteria

  • Current orthopaedic problems of lower limbs
  • History of severe cardiac condition
  • Premorbid major depression or psychosis
  • Unlikely to complete the intervention or return for second visit
  • Enrolment of the investigator, his/her family members, employees and other dependent persons

Treatment and study plan

2-minute walk test

Other

The patients will do a 2-minute walk test, using their walking aids or braces

Primary outcomes

  1. 2-minute walk test (meters an individual walks in 2 minutes)

    Time frame: 1-7 days

Secondary outcomes

  1. Inertia Measuring Unit data

    Time frame: 1-7 days

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Collaborators

  • Swiss Paraplegic Research, Nottwil

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Sep 21, 2020
Registry last updated
Jul 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.